NPRA1985

NPRA1985 | Joined since 2020-09-03

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

3,415

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
3,415
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2020-11-13 15:07 | Report Abuse

Moderna looks to first interim analysis in COVID-19 vaccine Phase 3 trial

https://www.biopharma-reporter.com/Article/2020/11/12/Moderna-looks-to-first-interim-analysis-in-COVID-19-vaccine-Phase-3-trial

-------------
Crucial Moderna Covid vaccine data is coming in days — here’s what to look out for

https://www.cnbc.com/2020/11/12/coronavirus-moderna-vaccine-data-is-coming-in-days-what-to-look-out-for.html

Stock

2020-11-13 14:59 | Report Abuse

Closing price 0.170

Stock

2020-11-13 12:02 | Report Abuse

When is the next quarter?

Stock

2020-11-13 10:39 | Report Abuse

Why price keep dropping?

Stock

2020-11-13 00:15 | Report Abuse

Some Etihad Cabin Crew Have Already Recieved Chinese COVID-19 Vaccination for Frontline Workers

The Sinopharm vaccine was developed in partnership with the Abu Dhabi artificial intelligence company Group 42. It uses an inactivated virus to generate an immune response to the novel Coronavirus and has been given to around 31,000 in the UAE, Egypt, Bahrain and Jordan as part of Phase III trials.

https://www.paddleyourownkanoo.com/2020/11/12/some-etihad-cabin-crew-have-already-recieved-chinese-covid-19-vaccination-for-frontline-workers/

Stock

2020-11-12 23:15 | Report Abuse

@MadCow75 I have a feeling the show will only start next week as tomorrow is Friday.

Stock

2020-11-12 22:52 | Report Abuse

Chinese companies could still emerge as frontrunners in vaccine distribution: The inactivated vaccines would be easier to distribute in poorer countries than the double-shot from Pfizer, which requires costly deep-freeze production, storage and transportation networks.

https://www.livemint.com/science/health/pfizer-success-shows-china-must-unveil-data-to-win-covid-19-vaccine-race-11605184882142.html

Stock

2020-11-12 22:52 | Report Abuse

Chinese companies could still emerge as frontrunners in vaccine distribution: The inactivated vaccines would be easier to distribute in poorer countries than the double-shot from Pfizer, which requires costly deep-freeze production, storage and transportation networks.

https://www.livemint.com/science/health/pfizer-success-shows-china-must-unveil-data-to-win-covid-19-vaccine-race-11605184882142.html

Stock

2020-11-12 22:38 | Report Abuse

Conducted in Morocco among others, Sinopharm’s Covid vaccine trials show «better-than-expected» data

We are impatiently awaiting the end of this process, which could probably happen by next week, to then receive the results from the Chinese laboratory», he concluded.

https://en.yabiladi.com/articles/details/101544/conducted-morocco-among-others-sinopharm-s.html

Stock

2020-11-12 22:36 | Report Abuse

Not Constellation Holdings?

Stock

2020-11-12 19:59 | Report Abuse

On the Covid-19 vaccine and development, he also thanked China’s contribution and support for Asean’s initiatives for public health emergencies.

“We look forward to the swift completion of the clinical trials of the vaccine, and appreciate (China’s) President Xi Jinping’s pledge to make the vaccine a ‘global public good’.

“On that note, Malaysia is appreciative of China’s commitment to prioritise Malaysia as a recipient, and we are now ready to receive successfully developed Covid-19 vaccines,” he said.

https://www.malaymail.com/news/malaysia/2020/11/12/malaysias-pm-calls-on-asean-and-china-to-leverage-on-digital-economy-post-c/1922056

Stock

2020-11-12 19:58 | Report Abuse

On the Covid-19 vaccine and development, he also thanked China’s contribution and support for Asean’s initiatives for public health emergencies.

“We look forward to the swift completion of the clinical trials of the vaccine, and appreciate (China’s) President Xi Jinping’s pledge to make the vaccine a ‘global public good’.

“On that note, Malaysia is appreciative of China’s commitment to prioritise Malaysia as a recipient, and we are now ready to receive successfully developed Covid-19 vaccines,” he said.

https://www.malaymail.com/news/malaysia/2020/11/12/malaysias-pm-calls-on-asean-and-china-to-leverage-on-digital-economy-post-c/1922056

Stock

2020-11-12 19:58 | Report Abuse

On the Covid-19 vaccine and development, he also thanked China’s contribution and support for Asean’s initiatives for public health emergencies.

“We look forward to the swift completion of the clinical trials of the vaccine, and appreciate (China’s) President Xi Jinping’s pledge to make the vaccine a ‘global public good’.

“On that note, Malaysia is appreciative of China’s commitment to prioritise Malaysia as a recipient, and we are now ready to receive successfully developed Covid-19 vaccines,” he said.

https://www.malaymail.com/news/malaysia/2020/11/12/malaysias-pm-calls-on-asean-and-china-to-leverage-on-digital-economy-post-c/1922056

Stock

2020-11-12 19:57 | Report Abuse

On the Covid-19 vaccine and development, he also thanked China’s contribution and support for Asean’s initiatives for public health emergencies.

“We look forward to the swift completion of the clinical trials of the vaccine, and appreciate (China’s) President Xi Jinping’s pledge to make the vaccine a ‘global public good’.

“On that note, Malaysia is appreciative of China’s commitment to prioritise Malaysia as a recipient, and we are now ready to receive successfully developed Covid-19 vaccines,” he said.

https://www.malaymail.com/news/malaysia/2020/11/12/malaysias-pm-calls-on-asean-and-china-to-leverage-on-digital-economy-post-c/1922056

Stock

2020-11-12 19:56 | Report Abuse

On the Covid-19 vaccine and development, he also thanked China’s contribution and support for Asean’s initiatives for public health emergencies.

“We look forward to the swift completion of the clinical trials of the vaccine, and appreciate (China’s) President Xi Jinping’s pledge to make the vaccine a ‘global public good’.

“On that note, Malaysia is appreciative of China’s commitment to prioritise Malaysia as a recipient, and we are now ready to receive successfully developed Covid-19 vaccines,” he said.

https://www.malaymail.com/news/malaysia/2020/11/12/malaysias-pm-calls-on-asean-and-china-to-leverage-on-digital-economy-post-c/1922056

Stock

2020-11-12 19:54 | Report Abuse

Malaysia ready to receive successfully developed Covid-19 vaccines — PM Muhyiddin

Malaysia is highly appreciative of China’s commitment to prioritise Malaysia as a recipient, and is now ready to receive successfully developed Covid-19 vaccines.

“Thus, we thank China’s contribution and support for ASEAN’s initiatives for public health emergencies.

“We look forward to the swift completion of the clinical trials of the vaccine, and appreciate President Xi Jinping’s pledge to make the vaccine a ‘global public good’,” he said.

https://www.edgeprop.my/content/1762065/malaysia-ready-receive-successfully-developed-covid-19-vaccines-—-pm-muhyiddin

Stock

2020-11-12 19:52 | Report Abuse

On the Covid-19 vaccine and development, he also thanked China’s contribution and support for Asean’s initiatives for public health emergencies.

“We look forward to the swift completion of the clinical trials of the vaccine, and appreciate (China’s) President Xi Jinping’s pledge to make the vaccine a ‘global public good’.

“On that note, Malaysia is appreciative of China’s commitment to prioritise Malaysia as a recipient, and we are now ready to receive successfully developed Covid-19 vaccines,” he said.

https://www.malaymail.com/news/malaysia/2020/11/12/malaysias-pm-calls-on-asean-and-china-to-leverage-on-digital-economy-post-c/1922056

Stock

2020-11-12 11:41 | Report Abuse

Pump and dump game lol bye bye. Come join Kanger instead.

Stock

2020-11-12 11:28 | Report Abuse

@Scenery Exactly. Friendship is very imaginative.

Stock

2020-11-12 11:27 | Report Abuse

lol Kstar is literally goreng stock. Pump and dump.

Stock

2020-11-12 11:20 | Report Abuse

Pfizer Vaccine will be targeting most vulnerable groups only in December. Front liners will be targeted in January.. The rest of the population end of Marh or early April.

"The US is planning start vaccinating the "most vulnerable" from next month if Pfizer's Covid-19 vaccine candidate is quickly approved by the drug regulators, US Health Secretary Alex Azar has said.

Pfizer is planning to ask the US Food and Drug Administration (FDA) for emergency use authorisation of its Covid-19 vaccine candidate very soon.

"In December we will be focusing on vaccinating the most vulnerable and then by the end of January we will have enough for all of our healthcare workers and first responders," Azar said.

The Health Secretary said that by the end of March or early April, the US should have enough vaccine for all Americans including other vaccines in the federal government's portfolio."

https://www.daijiworld.com/news/newsDisplay.aspx?newsID=770674

Stock

2020-11-12 10:47 | Report Abuse

Next up in hunt for COVID-19 vaccine: Testing shots in kids

Globally, pediatric studies are only hesitantly emerging. In China, Sinovac and SinoPharm have opened studies that can test children as young as 3.

https://www.ctvnews.ca/health/coronavirus/next-up-in-hunt-for-covid-19-vaccine-testing-shots-in-kids-1.5184740

Stock

2020-11-12 10:41 | Report Abuse

@angelo No idea. Syndicate controlling price. Other vaccine counters already rebounded.

Stock

2020-11-12 09:49 | Report Abuse

"Intuitively, it doesn't make sense to claim 92% protection just based on 20 events. But we'll have to see the data," he said. "

Scientists cautious as Russia says early data shows Sputnik V coronavirus vaccine is 92% effective

https://edition.cnn.com/2020/11/11/health/russia-vaccine-sputnik-coronavirus-intl/index.html

Stock

2020-11-12 09:42 | Report Abuse

@bowman Kanger will be working with Zuellig Pharma.

Stock

2020-11-12 09:41 | Report Abuse

Bursa healthcare index is down. Dow Jones is down. Have to wait until next week and see.

Stock

2020-11-12 09:29 | Report Abuse

Yes, thats unfortunate.

Stock

2020-11-12 09:24 | Report Abuse

After Biden is inagurated on 20 January 2021, he will issue a national face mask mandate. ProXmask will be well positioned to benefit from this mandate.

--------------------

"ProXmask™ registered with US FDA

The registration is expected to expand ProXmask™ export market horizon to the US market to curb Covid-19 pandemic."

https://www.theedgemarkets.com/content/advertise/proxmask-registered-with-us-fda
---------------------

"Prolexus Bhd’s wholly owned subsidiary, Honsin Apparel Sdn Bhd, obtained a CoR from Registrar Corp, which certifies that it has registered with the US FDA for face masks.

In a filing to Bursa Malaysia yesterday, Prolexus said this does not include the N95 respirator, while adding that the registration of CE marking with the EU is still in progress."

https://themalaysianreserve.com/2020/11/03/ppe-manufacturers-seek-certification-for-export-market/

Stock

2020-11-12 09:13 | Report Abuse

@kamjia01 AT is manipulated by KYY. He is the reason why.

Stock

2020-11-12 09:11 | Report Abuse

Colombia to start mass COVID-19 vaccination by early 2021

Colombia has signed confidentiality agreements with the six leading vaccine production companies Pfizer-BioNTech, Oxford-AstraZeneca, Janssen, SINOPHARM, CanSino and the Serum Institute of India.

http://thecitypaperbogota.com/news/colombia-to-start-mass-covid-19-vaccination-by-early-2021/26373

Stock

2020-11-12 09:08 | Report Abuse

Russia says its coronavirus vaccine is 92% effective, as battle to beat Western drugmakers heats up

https://www.cnbc.com/2020/11/11/coronavirus-vaccine-russia-says-its-vaccine-is-92percent-effective.html

Stock

2020-11-12 09:08 | Report Abuse

Russia says its coronavirus vaccine is 92% effective, as battle to beat Western drugmakers heats up

https://www.cnbc.com/2020/11/11/coronavirus-vaccine-russia-says-its-vaccine-is-92percent-effective.html

Stock

2020-11-12 09:00 | Report Abuse

Russia’s claim of a successful COVID-19 vaccine doesn’t pass the ‘smell test,’ critics say

In a press release, the Gamaleya National Center of Epidemiology and Microbiology in Moscow said an interim analysis of a large-scale trial underway in Russia had found 92% efficacy for its “Sputnik V” vaccine. The release quoted the Russian minister of health saying the results demonstrate that Sputnik V “is an efficient solution to stop the spread of coronavirus infection.” Yet it also noted the review covered just 20 TOTAL COVID-19 cases in the vaccinated and placebo groups—FAR TOO FEW FOR THE CLAIM BE CONVINCING, experts inside and outside of Russia say.

The U.S. Food and Drug Administration “WOULDN’T HAVE ACCEPTED A REPORT ON 20 CASES,,” says John Moore, a vaccine researcher at Weill Cornell Medical College. He regards the announcement as “Putinology,” referring to the Russian president. “Why is Russia doing this?” Moore asks. “It’s the international vaccine race. They want to be seen to be keeping up with their competitors in other countries. It’s clearly a rushed out announcement. But it doesn’t mean it’s wrong.”

https://www.sciencemag.org/news/2020/11/russia-s-claim-successful-covid-19-vaccine-doesn-t-pass-smell-test-critics-say

Stock

2020-11-12 03:07 | Report Abuse

Exactly my thoughts.

----------

Pfizer/BioNTech’s candidate requires two doses, USES UNPROVEN TECHNOLOGY, is in limited supply, and must be stored at -70°C.

‘We’re talking about a vaccine that has never been distributed in humans, and that is a vaccine made of messenger RNA – ribonucleic acid.

‘Before we even get to the almost presumptuous position of distribution, we really have to get final confirmation around safety.’

Professor Booy pointed out there has only been a median of AROUND TWO MONTHS OF FOLLOW UP for this candidate, and authorities ‘still need to do the due diligence and the appropriate safety monitoring’ before widely distributing it to the public.

‘It’s so exciting to think that tens of millions of doses could be produced for routine use this year, and over a billion doses are slated to be introduced next year,’ he said. ‘[But] WE JUST DO NOT YET KNOW IF THERE ARE MEDIUM-TO-LONG-TERM SIDE EFFECTS.

‘We need to be cautious not to jump on the hype train,’ he told newsGP. ‘The early data is based on a FAIRLY SMALL SAMPLE SIZE.

‘General practices generally have a pretty good on-site cold chain that is monitored as part of the accreditation standards, which will keep things within a temperature range – but our vaccine fridges don’t go down to -70°C.

‘THEY’RE AVAILABLE, BUT THEY’RE EXPENSIVE and they would require very specific handling protocols; -70°C is damn cold.

https://www1.racgp.org.au/newsgp/clinical/we-re-talking-about-a-vaccine-that-has-never-been

Stock

2020-11-12 02:42 | Report Abuse

Buying Covid-19 vaccines? Not so quick as no infrastructure yet, Dr Noor Hisham says

In a press conference today, Dr Noor Hisham highlighted the need for at least for a cold-chain with temperature as low as -80 degree Celsius in order to safely transport and store Covid-19 vaccines in Malaysia.

“Obviously, there are a lot of logistics issues,” he told a press conference.

“For example, there is a cold chain of -80 degrees that needs to be planned, and we would need to provide all that infrastructure before we can procure the vaccine.”

https://www.malaymail.com/news/malaysia/2020/11/10/buying-covid-19-vaccines-not-so-quick-as-no-infrastructure-yet-dr-noor-hish/1921347